Rodriguez-Valadez JM, Tahsin M, Fleischmann KE, et al
Immunoregulatory pathways controlling progression of autoimmunity in NOD mice: The role of CTLA-4 and TGF-
Saxenda (liraglutide) Saxenda is a GLP-1 medication appropriate for adults who: Have obesity (BMI of 30 or above) Have overweight (BMI of 27 or above) along with a weight-related comorbid condition like high blood pressure, type 2 diabetes, or high cholesterol or triglycerides It is also approved for children ages 12 and above who weigh more than 132 pounds and are considered obese
Some report a slight 'pulse' sensation or fullness
For brands, this moment creates an opportunity to redefine your product proposition
[25] [26] For other cancer types , including colorectal, breast, and prostate cancers, current evidence does not suggest increased risk with GLP-1 therapy